This inventor holds 1 USPTO granted patent. Top assignee: Astellas Pharma Gmbh. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Yuki Endo: Innovator in Insulin Resistance Research
Introduction
Yuki Endo is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of biochemistry, particularly in the area of insulin resistance and carbohydrate metabolism. His innovative work has led to the development of a unique polypeptide that has potential applications in pharmaceutical compositions.
Latest Patents
Yuki Endo holds a patent for a protein that binds to Akt2. This patent includes a novel polypeptide, a polynucleotide, an expression vector, and a method for screening agents that improve insulin resistance and carbohydrate metabolism. The polypeptide is particularly useful in identifying agents that can enhance insulin sensitivity. When overexpressed in fat cells, this polypeptide reduces the activity of Akt2, which is crucial for metabolic processes. The polynucleotide encodes the polypeptide, and the expression vector contains this polynucleotide. The screening method utilizes the polypeptide to discover potential agents for improving insulin resistance and carbohydrate metabolism. Furthermore, the production method incorporates the active ingredient obtained from the screening process into a pharmaceutical composition aimed at improving insulin resistance and carbohydrate metabolism.
Career Highlights
Yuki Endo is currently associated with Astellas Pharma GmbH, where he continues to advance his research in the field of metabolic disorders. His work has garnered attention for its potential impact on treating conditions related to insulin resistance.
Collaborations
Yuki Endo collaborates with esteemed colleagues, including Kazunori Inabe and Miyuki Kato, who contribute to his research endeavors. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Yuki Endo's contributions to the understanding of insulin resistance and carbohydrate metabolism through his patented innovations highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile